No Data
No Data
Pulmonx Director French Glendon E. III Sells $161,800 in Company Stock
Express News | Pulmonx Corp - 5-Year Data Show Durable Benefits of Zephyr Valves
Express News | Pulmonx Announces Presentation of Clinical Data From the Aeriseal® Convert Trial and 5-Year Follow-up Data From the Liberate Study at the European Respiratory Society Congress 2024
Pulmonx Announces Presentation of Clinical Data From the AeriSeal CONVERT Trial and 5-Year Follow-up Data From the LIBERATE Study at the European Respiratory Society Congress 2024
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Maintains Target Price $10
Aeriseal's Market Potential and Safety Profile: Justifying a Hold Rating for Pulmonx
No Data
No Data